In addition, treatments with BP-1-102, a STAT3 inhibitor, abolished resistance to cisplatin, indicating that the STAT3/NRF2/GPx4 signal has a critical function in the drug resistance of osteosarcoma cells [330]. The gene discussed is STAT3; the disease is osteosarcoma.